Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit
暂无分享,去创建一个
Chengren Li | Lan Xiao | Hanzhi Wang | H. Shen | F. Mei | Zhi Liu | Hong-kai Wang | Hongkai Wang | L. Xiao
[1] Lan Xiao,et al. Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia? , 2013, The international journal of neuropsychopharmacology.
[2] H. Kazui,et al. The KCNH2 gene is associated with neurocognition and the risk of schizophrenia , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[3] Jianrong Li,et al. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication , 2012, Neuroscience Research.
[4] H. Kinney,et al. Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte Injury , 2012, Brain pathology.
[5] L. Fañanás,et al. Neurodevelopmental liability to schizophrenia: The complex mediating role of age at onset and premorbid adjustment , 2011, Schizophrenia Research.
[6] S. Ludwin,et al. Neurobiological effects of sphingosine 1‐phosphate receptor modulation in the cuprizone model , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Christos Pantelis,et al. Age of onset of schizophrenia: perspectives from structural neuroimaging studies. , 2011, Schizophrenia bulletin.
[8] K. Davis,et al. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia , 2011, Progress in Neurobiology.
[9] C. Konradi,et al. Myelin, copper, and the cuprizone model of schizophrenia. , 2011, Frontiers in bioscience.
[10] J. Newcombe,et al. Contribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple Sclerosis , 2010, The Journal of Immunology.
[11] H. Naqvi,et al. Gender difference in age at onset of schizophrenia: a cross sectional study from Pakistan. , 2010, JPMA. The Journal of the Pakistan Medical Association.
[12] V. Haroutunian,et al. Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia , 2010, Schizophrenia Research.
[13] K. Fujihara,et al. Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination , 2010, Acta Neuropathologica.
[14] Haiyun Xu,et al. Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain , 2010, Schizophrenia Research.
[15] C. Beyer,et al. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia , 2009, Brain Research.
[16] Takahira Yamauchi,et al. Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] Martin Stangel,et al. Regional differences between grey and white matter in cuprizone induced demyelination , 2009, Brain Research.
[18] S. Floresco,et al. Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[19] R. Browning,et al. Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia , 2009, Brain Research.
[20] Richard Clough,et al. Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. , 2009, Behavioral neuroscience.
[21] Haiyun Xu,et al. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse , 2008, Schizophrenia Research.
[22] R. Franklin,et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency , 2008, Nature Neuroscience.
[23] J. He,et al. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes , 2008, Molecular Psychiatry.
[24] E. Vilella,et al. Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. , 2007, Toxicology letters.
[25] J. Decety,et al. Social brain dysfunctions in schizophrenia: A review of neuroimaging studies , 2006, Psychiatry Research: Neuroimaging.
[26] Cheuk Y. Tang,et al. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia , 2006, Annals of general psychiatry.
[27] W. F. Blakemore,et al. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice , 2006, Journal of Neuroimmunology.
[28] N. Jareborg,et al. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Neumaier,et al. Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle , 2006, Behavioural Brain Research.
[30] J. Garbern. Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis , 2006, Cellular and Molecular Life Sciences.
[31] Carl-Fredrik Westin,et al. DTI and MTR abnormalities in schizophrenia: Analysis of white matter integrity , 2005, NeuroImage.
[32] Dinesh Bhugra,et al. The Global Prevalence of Schizophrenia , 2005, PLoS medicine.
[33] K. Davis,et al. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia. , 2004, International review of neurobiology.
[34] Ueli Suter,et al. Quantifying the Early Stages of Remyelination Following Cuprizone‐induced Demyelination , 2003, Brain pathology.
[35] T. Kinoshita,et al. Diffusion Tensor Magnetic Resonance Imaging of Disruption of Regional White Matter in Schizophrenia , 2003, Neuropsychobiology.
[36] W. Honer,et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins , 2003, Molecular Psychiatry.
[37] Chao Zhao,et al. The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation , 2002, The Journal of Neuroscience.
[38] P. Morell,et al. The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.
[39] D. Weinberger,et al. From neuropathology to neurodevelopment , 1995, The Lancet.